Inventor

FLYNN DANIEL L

US122 patents

⚠️ This page may combine multiple inventors who share the name “FLYNN DANIEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FLYNN DANIEL L

DECIPHERA PHARMACEUTICALS LLC

Anti-inflammatory medicaments

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

Anti-inflammatory medicaments

Anti-inflammatory medicaments

Anti-inflammatory medicaments

Anti-inflammatory medicaments

Anti-cancer medicaments

Anti-inflammatory medicaments

Methods of treating disorders using CSF1R inhibitors

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

RAF inhibitor compounds

Raf inhibitor compounds

Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities

Methods for inhibiting tie-2 kinase useful in the treatment of cancer

1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities

Aminopyrimidine amide autophagy inhibitors and methods of use thereof

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Kinase inhibitors useful for the treatment of proliferative diseases

Methods of treating disorders using CSF1R inhibitors

Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

SEARLE & CO

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Method of using (H+ /K+)ATPase inhibitors as antiviral agents

Imidazopyridines as serotonergic 5-HT3 antagonists

Imidazopyridines as serotonergic 5-HT3 -antagonists

Intermediates useful in a process for the preparation of azanoradamantane benzamides

Imidazopyridines as serotonergic 5-HT3 antagonists

Indolones useful as serotonergic agents

Imidazopyridines as serotonergic 5-HT3 antagonists

Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents

FLYNN DANIEL L

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities

Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

N-acyl ureas exhibiting anti-cancer and anti-proliferative activities

Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Enzyme modulators and treatments

Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases

PHARMACIA CORP

Substituted pyrazoles as p38 kinase inhibitors

WARNER LAMBERT CO

N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

DECIPHERA PHARMACEUTICALS INC

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

LILLY CO ELI

Raf inhibitor compounds